CytomX Therapeutics, Inc.
COMPOSITIONS AND METHODS FOR CONJUGATING ACTIVATABLE ANTIBODIES

Last updated:

Abstract:

The invention relates generally to compositions and methods for conjugating antibodies and activatable antibodies, and methods of partially reducing antibodies and/or activatable antibodies prior to conjugation, e.g., thiol-based conjugation, with an agent, e.g., a therapeutic and/or diagnostic agent.

Status:
Application
Type:

Utility

Filling date:

9 Apr 2021

Issue date:

24 Mar 2022